162 related articles for article (PubMed ID: 18183621)
1. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment.
Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S
J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2]YFa-on antinociception and opioid receptor regulation.
Vats ID; Snehlata ; Nath M; Pasha MA; Pasha S
Eur J Pain; 2010 Mar; 14(3):295.e1-9. PubMed ID: 19560378
[TBL] [Abstract][Full Text] [Related]
3. Rationally designed chimeric peptide of met-enkephalin and FMRFa-[D-Ala2,p-Cl-Phe4]YFa induce multiple opioid receptors mediated antinociception and up-regulate their expression.
Vats ID; Chaudhary S; Sharma A; Nath M; Pasha S
Eur J Pharmacol; 2010 Jul; 638(1-3):54-60. PubMed ID: 20385120
[TBL] [Abstract][Full Text] [Related]
4. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebroventricularly administered chimeric peptide of metenkephalin and FMRFa--[D-Ala2]YFa-on antinociception and its modulation in mice.
Gupta S; Pasha S; Gupta YK; Bhardwaj DK
Brain Res Bull; 2001 May; 55(1):51-7. PubMed ID: 11427337
[TBL] [Abstract][Full Text] [Related]
6. Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa.
Gupta K; Vats ID; Gupta YK; Saleem K; Pasha S
Peptides; 2008 Dec; 29(12):2266-75. PubMed ID: 18930087
[TBL] [Abstract][Full Text] [Related]
7. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
Kumar K; Kumar S; Kurupati RK; Seth MK; Mohan A; Hussain ME; Pasha S
Eur J Pharmacol; 2011 Jan; 650(1):28-33. PubMed ID: 20887721
[TBL] [Abstract][Full Text] [Related]
8. Chimeric peptide of met-enkephalin and FMRFa: effect of chlorination on conformation and analgesia.
Hanif K; Gupta K; Gupta S; Gupta YK; Maiti S; Pasha S
Neurosci Lett; 2006 Jul; 403(1-2):131-5. PubMed ID: 16764989
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, conformational and pharmacological studies of glycosylated chimeric peptides of Met-enkephalin and FMRFa.
Masand G; Hanif K; Sen S; Ahsan A; Maiti S; Pasha S
Brain Res Bull; 2006 Jan; 68(5):329-34. PubMed ID: 16377439
[TBL] [Abstract][Full Text] [Related]
10. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
12. Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception.
Gupta S; Pasha S; Gupta YK; Bhardwaj DK
Peptides; 1999; 20(4):471-8. PubMed ID: 10458517
[TBL] [Abstract][Full Text] [Related]
13. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors.
Shu H; Arita H; Hayashida M; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2006 Jun; 106(2):263-71. PubMed ID: 16446067
[TBL] [Abstract][Full Text] [Related]
15. Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors.
Stanojević S; Vujić V; Mitić K; Kustrimović N; Kovacević-Jovanović V; Miletić T; Dimitrijević M
Neuropeptides; 2008 Apr; 42(2):147-58. PubMed ID: 18237778
[TBL] [Abstract][Full Text] [Related]
16. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
Pacheco Dda F; Romero TR; Duarte ID
Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.
Campbell VC; Taylor RE; Tizabi Y
Alcohol Clin Exp Res; 2007 Aug; 31(8):1435-40. PubMed ID: 17550364
[TBL] [Abstract][Full Text] [Related]
18. Endogenous peptide: Met-enkephalin-Arg-Phe, differently regulate expression of opioid receptors on chronic treatment.
Vats ID; Chaudhary S; Karar J; Nath M; Pasha Q; Pasha S
Neuropeptides; 2009 Oct; 43(5):355-62. PubMed ID: 19716174
[TBL] [Abstract][Full Text] [Related]
19. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
20. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
